omada health will prescribe glp-1 drugs starting in 2026. Radford Drug is adopting a new policy. GLP-1s, as well as many other brand-name are unfairly controlled by both drug manufacturers and PBMs. These companies wish to squash local competitors Inside Omada's pivot toward GLP-1

When prescribed safely and monitored by a provider, they are considered effective treatments for weight management and blood sugar control

Heise T, Mari A, DeVries JH, Urva S, Li J, Pratt EJ, et al

But it surely wont be the last, and the competition over the best obesity drug is only likely to heat up in the years to come.

There are some publicly available clinical trials, observational studies and case reports showing an association between gastroparesis or persistent vomiting and Ozempic and these types of drugs

The metabolic shifts caused by GLP-1RA treatment may affect cellular energy metabolism and alter inflammatory mediators in vestibular tissues